Pfizer/Inhale Therapeutic Look To Exubera Inhaled Insulin NDA Filing In 2001

Pfizer says it will file a new drug application (NDA) for Inhale Therapeutic Systems' insulin inhaler by year-end, after completion of a multi-center, Phase III trial testing the product in type 1 and type 2 diabetics.